4.7 Review

Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma

Michael G. White et al.

Summary: This study investigated the safety and feasibility of intraoperative portal vein blood (PVB) collection during pancreatic ductal adenocarcinoma (PDAC) resection. PVB circulating tumor cell (CTC) counts were significantly correlated with overall survival (OS), providing a potential new avenue for future research and clinical treatment.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Liquid biopsy enters the clinic - implementation issues and future challenges

Michail Ignatiadis et al.

Summary: The approval of liquid biopsy assays for detecting genetic alterations in plasma cell-free DNA has marked a tipping point for the clinical use of this technology, especially in patients with advanced-stage cancer. The next frontier is likely to be the systemic treatment of patients with 'ctDNA relapse' and other potential future applications include cancer screening and diagnosis.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Gastroenterology & Hepatology

Molecular pro fi ling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application

L. Sivapalan et al.

Summary: PDAC is expected to become the second leading cause of cancer-related mortality in the next decade, with limited treatment options and poor long-term prognosis. Liquid biopsies, particularly ctDNA analyses, are increasingly being studied as a promising avenue for enhancing the characterization of PDAC tumor genomes, potentially leading to new therapeutic targets and improved treatment stratification. Challenges in terms of technical, analytical and biological aspects need to be addressed for the full realization of the potential of liquid biopsies in PDAC management.

PANCREATOLOGY (2021)

Review Gastroenterology & Hepatology

Circulating tumour cells in pancreatic cancer: A systematic review and meta-analysis of clinicopathological implications

Tony C. Y. Pang et al.

Summary: CTCs are commonly detected in the peripheral circulation of PC patients, and may be associated with prognosis and disease stage. Portal vein blood contains more CTCs compared to peripheral blood, with different enrichment techniques yielding varied detection rates.

PANCREATOLOGY (2021)

Article Multidisciplinary Sciences

Circulating tumour cells as an indicator of early and systemic recurrence after surgical resection in pancreatic ductal adenocarcinoma

Yejong Park et al.

Summary: This study found that the presence of circulating tumor cells (CTCs) in the blood of PDAC patients can serve as an independent predictor for early and systemic recurrence after surgery. Patients with CTC positivity had a higher rate of systemic recurrence, indicating the importance of comprehensive systemic therapy and active monitoring for early recurrence in PDAC patients.

SCIENTIFIC REPORTS (2021)

Article Oncology

Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma

Gehan Botrus et al.

Summary: This study characterized the genomic alteration landscape of ctDNA in advanced PDAC patients, identifying therapeutically relevant alterations and providing a benchmark for further development in the field.

ONCOLOGIST (2021)

Review Cell Biology

Extracellular vesicles in pancreatic cancer progression and therapies

Chao-Hui Chang et al.

Summary: Pancreatic cancer is a leading cause of cancer-related deaths worldwide due to delayed diagnosis and limited treatments. Pancreatic ductal adenocarcinoma accounts for more than 90% of all pancreatic cancers, with extracellular vesicles playing a crucial role in regulating tumor growth and metastasis. Understanding the factors in EVs derived from pancreatic ductal adenocarcinoma can provide insights into potential early diagnosis and therapeutic strategies against this deadly cancer.

CELL DEATH & DISEASE (2021)

Article Multidisciplinary Sciences

Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice

Bashar Hamza et al.

Summary: This study presents a new method for measuring endogenous CTC kinetics by continuously exchanging blood between tumor-bearing and tumor-free mice. The research found varying half-life times of CTCs in circulation in different cancer models, and demonstrated the ability to generate distant metastases by transferring only 1-2% of shed CTCs. This technique is expected to further elucidate the role of CTCs and the rate-limiting steps in metastasis.

NATURE COMMUNICATIONS (2021)

Article Oncology

Preoperative CTC-Detection by CellSearch(R) Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer

Harald Hugenschmidt et al.

Summary: The presence of circulating tumor cells (CTCs) in preoperative samples of pancreatic cancer patients undergoing surgery was associated with earlier cancer metastasis and shorter survival, suggesting that CTCs may serve as a guide for initial treatment decisions in resectable pancreatic cancer patients.

CANCERS (2021)

Review Oncology

The Role of Exosomes in Pancreatic Cancer From Bench to Clinical Application: An Updated Review

Kai Chen et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a gastrointestinal malignancy with a low survival rate, and exosomes have potential roles in PDAC treatment strategies. Exosomes can serve as biomarkers and drug carriers in PDAC clinical applications, but obstacles still need to be overcome.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer

Alexander Semaan et al.

Summary: DEP-FFF was used to isolate CTCs in PDAC patients, revealing four distinct sub-populations including pEMT-CTCs, which were correlated with disease progression, survival, and recurrence. This highlights the importance of immunophenotyping and quantifying specific CTC sub-populations in PDAC.

BRITISH JOURNAL OF CANCER (2021)

Article Oncology

Circulating Tumor Cell Clusters Are Cloaked with Platelets and Correlate with Poor Prognosis in Unresectable Pancreatic Cancer

Minji Lim et al.

Summary: CTC clusters with mesenchymal characteristics and platelet marker expression are highly correlated with poor prognosis in patients with unresectable pancreatic cancer. Most CTCs in these patients are cloaked with platelets and the increase in CTC clusters is positively correlated with rapid disease progression, indicating their potential as prognostic markers and a target for personalized disease management.

CANCERS (2021)

Article Chemistry, Multidisciplinary

System Modularity Chip for Analysis of Rare Targets (SMART-Chip): Liquid Biopsy Samples

Thilanga N. Pahattuge et al.

Summary: Liquid biopsies are gaining popularity for their minimally invasive nature, potentially improving outcomes for patients. A system modularity chip (SMART-Chip) has been developed for the automated processing of circulating tumor cells (CTCs), reducing difficulties associated with manual handling and allowing for efficient analysis of rare targets.

ACS SENSORS (2021)

Article Oncology

Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes

Kirby P. Gardner et al.

Summary: Pancreatic cancer is difficult to diagnose and stage, prompting the need for diagnostic and prognostic biomarkers. CAML, a newly discovered circulating stromal cell, has shown potential in predicting disease stage and prognosis in PC patients.

NPJ PRECISION ONCOLOGY (2021)

Article Multidisciplinary Sciences

Prognostic value of circulating tumor cells in patients with bladder cancer: A meta-analysis

Hui Jiang et al.

Summary: This meta-analysis included 11 eligible studies with a total of 1,062 BC patients. Overall analysis showed that CTC-positive patients had poorer survival and more aggressive disease progression than CTC-negative patients. Subgroup analyses confirmed that the presence of CTCs predicted a high risk of mortality and disease progression in most subgroups.

PLOS ONE (2021)

Review Oncology

Better together: circulating tumor cell clustering in metastatic cancer

Emma Schuster et al.

Summary: CTC clusters play a crucial role in cancer, with a higher metastatic potential and unfavorable clinical outcomes compared to single CTCs. While the mechanism of CTC cluster formation is still unclear, certain cell adhesion molecules and tight junction proteins have been identified as key factors.

TRENDS IN CANCER (2021)

Review Biochemical Research Methods

The pre-analytical phase of the liquid biopsy

Francesca Salvianti et al.

NEW BIOTECHNOLOGY (2020)

Article Genetics & Heredity

Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution

Michelle Chan-Seng-Yue et al.

NATURE GENETICS (2020)

Article Multidisciplinary Sciences

Ultrahigh-throughput magnetic sorting of large blood volumes for epitope-agnostic isolation of circulating tumor cells

Avanish Mishra et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

Non-invasive early detection of cancer four years before conventional diagnosis using a blood test

Xingdong Chen et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target

Joseph W. Franses et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Neutrophils escort circulating tumour cells to enable cell cycle progression

Barbara Maria Szczerba et al.

NATURE (2019)

Article Biochemistry & Molecular Biology

A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma

Nikki K. Lytle et al.

Review Oncology

Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma

Etienne Buscail et al.

CANCERS (2019)

Review Gastroenterology & Hepatology

Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer

Masayuki Kitano et al.

JOURNAL OF GASTROENTEROLOGY (2019)

Article Oncology

Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer

Hitendra Patel et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Article Surgery

Surveillance for pancreatic cancer in high-risk individuals

I. C. A. W. Konings et al.

BJS OPEN (2019)

Article Medicine, General & Internal

Pancreatic cancer An update on diagnosis and management

Benjamin P. T. Loveday et al.

AUSTRALIAN JOURNAL OF GENERAL PRACTICE (2019)

Article Multidisciplinary Sciences

Quantifying circulating cell-free DNA in humans

Romain Meddeb et al.

SCIENTIFIC REPORTS (2019)

Review Biochemistry & Molecular Biology

Current Progresses of Exosomes as Cancer Diagnostic and Prognostic Biomarkers

Tao Huang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)

Article Oncology

Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer

Colin M. Court et al.

ANNALS OF SURGICAL ONCOLOGY (2018)

Article Oncology

Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer

Katharina E. Effenberger et al.

CLINICAL CANCER RESEARCH (2018)

Review Engineering, Biomedical

Profiling circulating tumour cells and other biomarkers of invasive cancers

Mahla Poudineh et al.

NATURE BIOMEDICAL ENGINEERING (2018)

Article Pathology

Pancreatic cancer circulating tumor cells: applications for personalized oncology

Benjamin J. DiPardo et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)

Article Biochemical Research Methods

The RareCyte® platform for next-generation analysis of circulating tumor cells

Eric P. Kaldjian et al.

CYTOMETRY PART A (2018)

Review Surgery

Surgical treatment of pancreatic cancer

Wioletta Masiak-Segit et al.

POLISH JOURNAL OF SURGERY (2018)

Review Oncology

CTC clusters in cancer progression and metastasis

Anna Fabisiewicz et al.

MEDICAL ONCOLOGY (2017)

Article Biochemistry & Molecular Biology

Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer

Yu Xu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Multidisciplinary Sciences

Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer

Sushrut Kamerkar et al.

NATURE (2017)

Review Biotechnology & Applied Microbiology

Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis

Qingcai Meng et al.

ONCOTARGETS AND THERAPY (2017)

Article Oncology

Metabolomic biomarkers of pancreatic cancer - a meta-analysis study

Khyati Y. Mehta et al.

ONCOTARGET (2017)

Article Multidisciplinary Sciences

Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations

Birte Kulemann et al.

SCIENTIFIC REPORTS (2017)

Article Oncology

Cytologic Characteristics of Circulating Epithelioid Cells in Pancreatic Disease

Matthew W. Rosenbaum et al.

CANCER CYTOPATHOLOGY (2017)

Article Oncology

Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer

J. S. Ankeny et al.

BRITISH JOURNAL OF CANCER (2016)

Review Multidisciplinary Sciences

Metastatic colonization by circulating tumour cells

Joan Massague et al.

NATURE (2016)

Article Multidisciplinary Sciences

Genomic analyses identify molecular subtypes of pancreatic cancer

Peter Bailey et al.

NATURE (2016)

Review Gastroenterology & Hepatology

The role of endoscopic ultrasound in pancreatic cancer screening

Manoop S. Bhutani et al.

ENDOSCOPIC ULTRASOUND (2016)

Article Surgery

Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings

Christy E. Cauley et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)

Article Gastroenterology & Hepatology

Circulating Tumor Cells Found in Patients With Localized and Advanced Pancreatic Cancer

Birte Kulemann et al.

PANCREAS (2015)

Article Biochemistry & Molecular Biology

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Dong Gao et al.

Article Gastroenterology & Hepatology

Detection of Circulating Pancreas Epithelial Cells in Patients With Pancreatic Cystic Lesions

Andrew D. Rhim et al.

GASTROENTEROLOGY (2014)

Article Biochemistry & Molecular Biology

Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer

Cassandra L. Hodgkinson et al.

NATURE MEDICINE (2014)

Article Gastroenterology & Hepatology

Circulating tumor cells in pancreatic cancer patients: Enrichment and cultivation

Vladimir Bobek et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Review Pathology

Microfluidics and Circulating Tumor Cells

Yi Dong et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2013)

Article Medicine, General & Internal

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Biochemistry & Molecular Biology

EMT and Dissemination Precede Pancreatic Tumor Formation

Andrew D. Rhim et al.

Article Gastroenterology & Hepatology

EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis

Michael Jonathan Hewitt et al.

GASTROINTESTINAL ENDOSCOPY (2012)

Article Medicine, General & Internal

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Marco Gerlinger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Review Gastroenterology & Hepatology

Assessment of morbidity and mortality associated with EUS-guided FNA: a systematic review

Kai-Xuan Wang et al.

GASTROINTESTINAL ENDOSCOPY (2011)

Article Medicine, General & Internal

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Multidisciplinary Sciences

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

Shinichi Yachida et al.

NATURE (2010)

Review Radiology, Nuclear Medicine & Medical Imaging

Imaging of benign and malignant cystic pancreatic lesions and a strategy for follow up

Priya Bhosale et al.

WORLD JOURNAL OF RADIOLOGY (2010)

Article Gastroenterology & Hepatology

Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result

Toshio Kurihara et al.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2008)

Review Oncology

Detecting early pancreatic cancer: Problems and prospects

Suresh T. Chari

SEMINARS IN ONCOLOGY (2007)

Review Biochemistry & Molecular Biology

Circulating nucleic acids (CNAs) and cancer - A survey

M. Fleischhacker et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2007)

Article Immunology

Exosomal-like vesicles are present in human blood plasma

MP Caby et al.

INTERNATIONAL IMMUNOLOGY (2005)